Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A large-scale c-Fos brain mapping study on extinction of cocaine-primed reinstatement
    Published on 2024-04-25
    2 years ago
  • Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
    Published on 2024-04-24
    2 years ago
  • Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits
    Published on 2024-04-24
    2 years ago
  • Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
    Published on 2024-04-23
    2 years ago
  • Substance P in the medial amygdala regulates aggressive behaviors in male mice
    Published on 2024-04-22
    2 years ago
  • Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
    Published on 2024-04-22
    2 years ago
  • Neural effects of psychedelics: Complexity the key word
    Published on 2024-04-16
    2 years ago
« Previous 1 … 82 83 84 85 86 … 143 Next »
Journal of Psychopharmacology
  • The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
    Published on 2022-01-04
    4 years ago
  • Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
    Published on 2022-01-04
    4 years ago
  • Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction
    Published on 2022-01-04
    4 years ago
  • Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans
    Published on 2021-12-31
    4 years ago
  • Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
    Published on 2021-12-17
    4 years ago
  • Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA
    Published on 2021-12-13
    4 years ago
  • Prospective memory deficits following acute alcohol consumption
    Published on 2021-11-06
    5 years ago
« Previous 1 … 82 83 84 85 86 … 145 Next »
European Neuropsychopharmacology
  • Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder
    Published on 2022-06-17
    4 years ago
  • Requiem or resurrection: Classic monoamine oxidase inhibitors revisited
    Published on 2022-06-14
    4 years ago
  • A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia
    Published on 2022-06-12
    4 years ago
  • Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art
    Published on 2022-06-04
    4 years ago
  • A pacemaker for happiness – Transcutaneous vagus nerve stimulation in depression
    Published on 2022-06-03
    4 years ago
  • Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
    Published on 2022-06-03
    4 years ago
  • Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice
    Published on 2022-06-03
    4 years ago
« Previous 1 … 82 83 84 85 86 … 166 Next »

   Pharma Pub